Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

AUP Insider Trading (Aurinia Pharmaceuticals)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$2,227,165.60
Insider Selling (Last 12 Months): C$3,919,165.00

Aurinia Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Aurinia Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aurinia Pharmaceuticals Share Price & Price History

Current Price: C$16.76
Price Change: Price Decrease of -0.61 (-3.51%)
As of 07/30/2021 01:00 AM ET

This chart shows the closing price history over time for AUP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The Safest Way To Start Trading Is Here!
One look at Wall Street right now and anyone can tell: it’s a mess! But new trades can get an edge with “Options Trading Made Easy” by trading champion Chuck Hughes, the best guide to options trading in the modern market.

Start with a small investment today and see where you can go!

Get your copy now!
>>>

Aurinia Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/11/2021Michael Robert MartinDirectorBuy29,000C$28.82C$835,780.0061,824
11/10/2021Neil SolomonsSenior OfficerBuy70,000C$8.00C$559,944.00157,299
11/9/2021Michael Robert MartinDirectorSell50,000C$39.82C$1,991,220.0092,824
10/25/2021Robert HuizingaSenior OfficerBuy95,000C$4.22C$401,280.00195,728
9/21/2021Robert HuizingaSenior OfficerBuy16,000C$3.47C$55,545.60122,092
9/20/2021Michael Robert MartinDirectorBuy28,500C$7.00C$199,386.00171,324
9/13/2021Michael Robert MartinDirectorBuy25,000C$7.01C$175,230.00167,824
9/10/2021Robert HuizingaSenior OfficerSell32,500C$27.92C$907,335.00106,092
9/7/2021Michael Robert MartinDirectorSell7,500C$23.89C$179,190.00142,824
9/7/2021Robert HuizingaSenior OfficerSell5,000C$24.16C$120,780.00138,592
8/26/2021Michael Robert MartinDirectorSell22,500C$23.51C$528,957.00150,324
8/25/2021Neil SolomonsSenior OfficerSell5,000C$20.92C$104,610.00137,299
7/28/2021Michael Robert MartinDirectorSell5,000C$17.41C$87,073.00177,824
6/22/2021Michael Robert MartinDirectorSell5,000C$17.01C$85,050.00182,824
1/28/2021Stephen P. RobertsonSenior OfficerBuy900C$21.30C$19,174.322,720
9/21/2020Chin Kyu HuhInsiderSell48,458C$19.91C$964,988.546,499,881
8/18/2020Robert HuizingaSenior OfficerSell14,000C$19.01C$266,176.40103,592
7/8/2020Neil SolomonsSenior OfficerSell10,000C$21.15C$211,500.00187,299
4/9/2020Neil SolomonsSenior OfficerSell4,100C$21.04C$86,279.17197,299
4/6/2020Neil SolomonsSenior OfficerSell15,000C$21.11C$316,617.00202,299
1/2/2020Dennis BourgeaultSenior OfficerSell3,000C$27.62C$82,860.0070,891
12/16/2019Dennis BourgeaultSenior OfficerSell5,000C$24.08C$120,400.0073,891
12/12/2019Dennis BourgeaultSenior OfficerSell5,000C$24.55C$122,750.0016,452
10/15/2019Joseph Patrick HaganDirectorBuy2,000C$6.28C$12,553.203,500
10/14/2019Bradley DickersonSenior OfficerBuy5,000C$5.11C$25,542.0015,000
10/11/2019Joseph Patrick HaganDirectorBuy1,500C$5.11C$7,660.031,500
9/26/2019Stephen P. RobertsonSenior OfficerBuy1,050C$7.44C$7,812.001,820
See Full Table
Make Sure Your Alarm Is Set…
This early morning trade is constantly overlooked, but those who use it are retiring early!

Hi, I’m trading expert Dave Aquino and with my new guide, “How To Master The Retirement Trade”, you could be taking advantage of it as well!

The trade starts at 9:30EST…don’t be late!

Get a copy here!

>>>

SEC Filings (Institutional Ownership Changes) for Aurinia Pharmaceuticals (TSE:AUP)

Aurinia Pharmaceuticals logo
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.
Read More on Aurinia Pharmaceuticals

Today's Range

Now: C$16.76
Low: C$16.41
High: C$17.46

50 Day Range

MA: N/A

52 Week Range

Now: C$16.76
Low: C$11.77
High: C$26.00

Volume

4,611,683 shs

Average Volume

229,895 shs

Market Capitalization

C$2.15 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals' top insider shareholders include:
  1. Chin Kyu Huh (Insider)
  2. Robert Huizinga (Senior Officer)
  3. Neil Solomons (Senior Officer)
  4. Michael Robert Martin (Director)
  5. Stephen P Robertson (Senior Officer)
Learn More about top insider investors at Aurinia Pharmaceuticals.
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.